{"title":"A survey of emergency physicians' prescription of piperacillin/tazobactam.","authors":"Sofie Damgaard Mortensen, Sanne Schjødt, Marianne Lisby","doi":"10.61409/A11240794","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Piperacillin/tazobactam (Pip/Taz) is a broad-spectrum antibiotic, often prescribed in emergency departments (EDs). Excessive use of broad-spectrum antibiotics may lead to the rise of antimicrobial resistance, a concerning health issue. We investigated physicians' adherence to regional guidelines and their considerations when prescribing Pip/Taz in the ED.</p><p><strong>Methods: </strong>In this cross-sectional survey, a ten-item survey questionnaire was administered to ED physicians in five EDs from 10 January to 7 February 2024.</p><p><strong>Results: </strong>A total of 261 physicians employed in the ED were invited to participate in the survey. Among these, 144 physicians completed the survey, yielding a response rate of 55.2%. Based on the results, 25% were unaware of the regional guidelines on the prescription of Pip/Taz. In addition, over the past month, 25% had prescribed Pip/Taz in situations where regional guidelines recommended a narrow-spectrum antibiotic, primarily because of concerns regarding the patient's condition (74.3%); 30.6% of those who deviated from guidelines were consultants.</p><p><strong>Conclusions: </strong>This study found that a fourth of physicians in EDs were unaware of regional guidelines for prescribing Pip/Taz. Moreover, one in every four physicians purposely deviated from the recommended type of antibiotics, mainly because of concerns about the patient's clinical condition.</p><p><strong>Funding: </strong>None.</p><p><strong>Trial registration: </strong>Not relevant.</p>","PeriodicalId":11119,"journal":{"name":"Danish medical journal","volume":"72 10","pages":""},"PeriodicalIF":1.2000,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Danish medical journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.61409/A11240794","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Piperacillin/tazobactam (Pip/Taz) is a broad-spectrum antibiotic, often prescribed in emergency departments (EDs). Excessive use of broad-spectrum antibiotics may lead to the rise of antimicrobial resistance, a concerning health issue. We investigated physicians' adherence to regional guidelines and their considerations when prescribing Pip/Taz in the ED.
Methods: In this cross-sectional survey, a ten-item survey questionnaire was administered to ED physicians in five EDs from 10 January to 7 February 2024.
Results: A total of 261 physicians employed in the ED were invited to participate in the survey. Among these, 144 physicians completed the survey, yielding a response rate of 55.2%. Based on the results, 25% were unaware of the regional guidelines on the prescription of Pip/Taz. In addition, over the past month, 25% had prescribed Pip/Taz in situations where regional guidelines recommended a narrow-spectrum antibiotic, primarily because of concerns regarding the patient's condition (74.3%); 30.6% of those who deviated from guidelines were consultants.
Conclusions: This study found that a fourth of physicians in EDs were unaware of regional guidelines for prescribing Pip/Taz. Moreover, one in every four physicians purposely deviated from the recommended type of antibiotics, mainly because of concerns about the patient's clinical condition.
期刊介绍:
The Danish Medical Journal (DMJ) is a general medical journal. The journal publish original research in English – conducted in or in relation to the Danish health-care system. When writing for the Danish Medical Journal please remember target audience which is the general reader. This means that the research area should be relevant to many readers and the paper should be presented in a way that most readers will understand the content.
DMJ will publish the following articles:
• Original articles
• Protocol articles from large randomized clinical trials
• Systematic reviews and meta-analyses
• PhD theses from Danish faculties of health sciences
• DMSc theses from Danish faculties of health sciences.